FDA Restricts the Use of Liver Disease Medicine Ocaliva For Risk of Serious Liver Injury
06/03/2021
Meyers & Flowers is currently investigating potential Ocaliva chronic liver disease lawsuits for individuals with primary biliary cholangitis (PBC) who have suffered serious liver injuries after taking the drug. The U.S. Food and Drug Administration recently restricted the use of the liver disease medicine Ocaliva in patients that have primary biliary cholangitis with advanced cirrhosis of th...
View More